RecruitingNot ApplicableNCT07298109

Diaphragmatic Release for Low Back Pain

Investigating the Effectiveness of Diaphragmatic Release in Patients With Low Back Pain.


Sponsor

Karabuk University

Enrollment

42 participants

Start Date

Dec 11, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Low back pain is one of the most common musculoskeletal disorders, significantly affecting the quality of life of individuals. In non-specific low back pain, a lack of stabilization in the core region negatively impacts the performance of activities. The diaphragm forms the framework of the core region, and its dysfunction can contribute to both respiratory problems and low back pain. This study will investigate the effects of diaphragm relaxation, added to spinal stabilization exercises, on pain, disability, quality of life, central sensitization, and trunk muscle endurance.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Control and Manual diaphragm release for people with diaphragm; relaxation and low back pain. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERManual diaphragm release

In addition to spinal stabilization exercises, patients will perform diaphragmatic relaxation exercises three days a week for eight weeks.

OTHERControl

Patients will undergo spinal stabilization exercises three times a week for eight weeks.


Locations(1)

Karabuk University, Physiotherapy and Rehabilitation Application and Research Center

Karabük, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07298109


Related Trials